Clinical researchers at Indiana University School of Medicine are using personalized medicine to treat patients at the Precision Genomics clinic. The goal is to find drugs that work well on a patient's tumor, while also having fewer side effects.
For decades, researchers have characterized cancer based on where it starts, calling a disease, "breast cancer," because it starts in the breast. Now they can take a closer look at the disease and find that it may actually be a different kind of cancer that has spread to the breast. Leaders of the program say this individualized approach can lead them to look at various kinds of cancer differently.
"Every cancer has its own unique fingerprint," said Milan Radovich, PhD, who is the co-leader of the IU Health Precision Genomics Program. "I think the future of drug development is taking that individualized, unique fingerprint, developing drugs that are designed for each particular patient, and being able to attack cancer on an individual level."